Human Subjects Protection

• Comments on FDA Draft Guidance on Using a Centralized IRB Process
  (May 27, 2005)

• Protecting Research and Research Participants

• Testimony of Charles A. Johnson, MBChB on behalf of the Biotechnology Industry Organization (BIO) before the Senate Committee on Health, Education, Labor and Pensions (April 23, 2002)

About advertising opportunities